BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 12708878)

  • 1. [Drugs and arterial stiffness in hypertensive patients].
    Laurent S
    Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictors of cardiovascular mortality and morbidity in hypertension].
    Laurent S
    Curr Med Res Opin; 2005; 21 Suppl 5():S7-11. PubMed ID: 16197646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systolic, diastolic and pulse pressure: therapeutic options].
    Montereggi A
    Ital Heart J Suppl; 2001 Apr; 2(4):375-80. PubMed ID: 19397010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulse pressure in the therapeutic management of hypertension?].
    Scholze J
    Herz; 2004 May; 29(3):276-89. PubMed ID: 15167954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
    J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-artery stiffness, hypertension and cardiovascular risk in older patients.
    Blacher J; Safar ME
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):450-5. PubMed ID: 16265585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rigidity of large arteries and cardiovascular risk. epidemiological aspects and genetic determinants].
    Lajemi M; Gautier S; Benetos A
    Pathol Biol (Paris); 1999 Jun; 47(6):614-22. PubMed ID: 10472072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockade in the challenging era of systolic hypertension.
    Stergiou GS
    J Hum Hypertens; 2004 Dec; 18(12):837-47. PubMed ID: 15318161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.